Sun Pharma arm Taro plans share repurchase worth $250m

Taro Pharmaceutical Industries Ltd, the Israeli subsidiary of Sun Pharmaceutical Industries Ltd, on Wednesday said its board has approved the repurchase of shares worth $250 million.

Continue reading this story with a subscription to DealStreetAsia.

Subscribe

Contact us for corporate subscriptions at subs@dealstreetasia.com.